Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

[video] Biotech's Next Big Thing: Fall Trials
TheStreet.com
Friday, August 23, 2013 - 10:20am
tags:
clinical trials, Biodel, Coronado Biosciences, Achillion, BIOD-531, hepatitis C, pig whip worms
Women's health startup solicits crowd-funding for at-home breast exam device
Mass Device
Friday, August 23, 2013 - 10:14am
tags:
breast cancer, crowd-funding, Eclipse Breast Health Technologies, devices
The Disruptive Potential Of Inovio's SynCon DNA Vaccines
Seeking Alpha
Friday, August 23, 2013 - 9:43am
tags:
Inovio, SynCon, DNA vaccines, vaccines
Galena: 2 Goldmine Drugs For Cancer
Seeking Alpha
Friday, August 23, 2013 - 9:35am
tags:
Galena Biopharma, NeuVax, breast cancer, Abstral, breakthrough pain
ChinaGate: Former Lilly Manager Says Docs Were Paid $5 Million
Pharmalot
Friday, August 23, 2013 - 9:34am
tags:
physician payments, China, Eli Lilly
Antipsychotics Can Triple The Risk That Children Develop Diabetes
Pharmalot
Friday, August 23, 2013 - 9:29am
tags:
diabetes, antipsychotics
The Past, Present, and Future of Alzheimer’s Treatments
Motley Fool
Friday, August 23, 2013 - 9:26am
tags:
Alzheimer's disease, Aricept, Pfizer, Eisai, Actavis, Namenda, Eli Lilly, Forest Labs, bapineuzumab, JNJ, Elan, Perrigo Company, solanezumab, PBT2, Prana Biotechnology
Controversial Biosimilar Legislation Heats Up In California
Forbes
Thursday, August 22, 2013 - 5:40pm
tags:
biosimilars, California
Who Will Be the Winner in the Fight Against Obesity?
Motley Fool
Thursday, August 22, 2013 - 5:37pm
tags:
obesity, Vivus, Qsymia, Belviq, Eisai, Arena Pharmaceuticals, Contrave, Orexigen
Amgen Said to Push for Lower Onyx Price Amid Data Dispute
Bloomberg
Thursday, August 22, 2013 - 5:36pm
tags:
Amgen, ONYX Pharmaceuticals, M&A
Biotech Buyouts: Who's Next?
Motley Fool
Thursday, August 22, 2013 - 5:35pm
tags:
M&A, ONYX Pharmaceuticals, Amgen, Seattle Genetics, Medivation, Incyte
Mission Pharmacal launches urology-drug sales force
Bizjournals.com
Thursday, August 22, 2013 - 11:41am
tags:
urology, Mission Pharmacal, Urocit-K, kidney stones
Onyx Pharmaceuticals Gains 3% as Impediment to Takeover Reported Removed
Barron's
Thursday, August 22, 2013 - 11:35am
tags:
ONYX Pharmaceuticals, M&A
Celgene's Multiple Myeloma Powerhouse
Motley Fool
Thursday, August 22, 2013 - 11:21am
tags:
Multiple Myeloma, Celgene, Thalomid, Revlimid, Pomalyst
Boston Scientific wins FDA nods for electrophysiology tech
Fierce Medical Devices
Thursday, August 22, 2013 - 10:38am
tags:
FDA, Boston Scientific, devices, electrophysiology, IntellaTip, Rhythmia, Zurpaz
Alexion: Is There Any Remaining Value in This Industry Leader?
Motley Fool
Thursday, August 22, 2013 - 10:36am
tags:
Alexion, Soliris
Horizon Pharma Enters Settlement Agreements With Par Pharmaceutical
Seeking Alpha
Thursday, August 22, 2013 - 10:35am
tags:
Par Pharmaceutical, Horizon Pharma, Duexis
Takeda’s Experimental Bowel Drug Shown Effective, Studies Find
Bloomberg/Businessweek
Thursday, August 22, 2013 - 10:10am
tags:
ulcerative colitis, Chron's Disease, Takeda, vedolizumab
Regado misses IPO fiesta, limps into public spotlight with $43M raise
Fierce Biotech
Thursday, August 22, 2013 - 10:08am
tags:
IPOs, Regado Biosciences
Four Promising Biotech Stocks With Upcoming Catalysts
Minyanville
Thursday, August 22, 2013 - 10:05am
tags:
GSK, Sarepta, Gilead, sofosbuvir, SGX203, SGX942, Soligenix, drisapersen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.